Authors achieved a significant reduction in PGE2 and ICAM-1 expression levels, as well as a reduction in STAT-3 phosphorylation levels by inhibiting sPLA2 in lung cancer cells [171,172]. Here, PLA2G2A is linked to lung carcinoma.